Significant Details For New Therapy for Gynecologic Cancer – The Options
Posted on 22 January 2012
Sufferers who have gynecologic cancer have new optimism in a original technology currently offered at the Seidman Cancer Center at University Hospitals Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.
Carried out immediately following surgical treatment, HIPEC delivers heated chemotherapy through a ‘hot bath’ into the abdominal cavity, where it can penetrate diseased tissue directly. After the physician removes the maximum visible cancer as possible, a heated, a sterilized chemotherapy solution is distributed throughout the midsection by using a technically advanced perfusion technique to eliminate the residual cancer cells.
“This is a new and potentially revolutionary way of treating women with gynecologic cancers, which tend to be quite responsive to chemotherapy,” says Dr. DeBernardo, gynecologic oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “Our preliminary data and experience has been overwhelmingly positive and the therapy has been well-tolerated and effective. HIPEC promises to extend lives in a meaningful way.”
HIPEC has been used for years for public health care in patients with colon, pseudomyxomas, malignant mesothelioma and appendiceal cancer, varieties of cancer that generally speaking aren’t receptive to chemotherapy, but it’s currently viewed as a promising fresh treatment method for gynecologic malignancy.
Responses are closed for this post.